Virtual CME Program

1.00 CME/CE Credit

Gut Club: Advances in Irritable Bowel Syndrome and Colorectal Cancer Screening

Stay current on two high-impact GI topics relevant to every primary care practice. This activity covers the latest evidence-based treatments for IBS and chronic idiopathic constipation alongside a practical look at colorectal cancer screening with an emphasis on non-invasive tests—giving you actionable guidance you can apply with your patients right away.

Begin

CME/CE Information

1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 1.00 AANP, including 0.50 AANP Pharm

Release Date: 6/10/2026

Expiration Date: 6/9/2027

Topics

Faculty

Philip Schoenfeld, MD, MSEd, MSc

Learning Objectives

Discuss efficacy, safety, and evidence-based guidelines of IBS and CIC treatment with OTC and prescription therapies
Discuss strengths and limitations of non-invasive tests for CRC screening

Faculty

Philip Schoenfeld, MD, MSEd, MSc

Chief, Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, Michigan

Learn More

Disclosures

The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All relevant relationships have been mitigated by Pri-Med Institute:

Philip Schoenfeld, MD, MSEd, MSc: Consultant for Ironwood Pharmaceuticals and AbbVie Pharmaceuticals; Advisor for Exact Sciences; Speaker for Phathom Pharmaceuticals and Nestle Health Science; Advisor and Speaker for Ardelyx Pharmaceuticals.

Pamela Kushner, MD, FAAFP (Moderator): Speaker for Phathom; Advisor for Bausch/Salix; Advisor and Speaker for Boehringer Ingelheim, Novo Nordisk, and Lilly; Advisor for Verdiva and Abbott.

All other individuals in control of content for this activity have disclosed no relevant financial relationships.

CME/CE Information

AMA PRA Category 1 Credits™

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and EBMed. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of Pri-Med Institute and EBMed.Pri-Med Institute is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider Number 040308.

Designation Statement

This activity is approved for 1.00 contact hour of continuing education, which includes 0.50 hours of pharmacology.

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, and 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit. Pri-Med Institute reports completion information to ACCME on a monthly basis, in the first week of each month.

Instructions for Obtaining Credit

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 3 out of the 4 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.

Supported by

Ironwood Pharmaceuticals, Inc. (in partnership with AbbVie Inc), Ardelyx, Inc., and Exact Sciences Corporation

Education Partner

EBMed

Fine Print

Computer System Requirements

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Statement of Independence

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Disclosure Policies and Contacting Pri-Med Institute

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.